REG-Ashoka WhiteOak Emerging Markets Trust Plc: 2Q Update - June 2025

Ashoka WhiteOak Emerging Markets TrustAnnouncement

22/07/2025 07:02

22 July 2025

 

Ashoka WhiteOak Emerging Markets Trust plc

(the `Company')

 

2Q Update - June 2025

 

The Company's monthly factsheet as at 30 June 2025 is now available:
https://awemtrust.com/factsheet/

 

The Fund was up 6.1% in 2Q 2025, outperforming the benchmark by 0.64%. The key
contributors include Sk Hynix (+57.6%), OneSource Specialty Pharma (+16.5%),
and Vivara Participacoes (+38.8%), whereas Alibaba (-5.1%), Yum China (-
18.7%), and E Ink Holdings (-10.7%) were the key detractors.

 

Market Review

 

In 2Q 2025, the MSCI EM index was up 5.5%. It outperformed other global
indices like the US equities (S&P 500) and MSCI World which returned 4.3% and
4.9%, respectively.

 

For the quarter, IT Services and Industrials outperformed, while Consumer
Discretionary and Real Estate underperformed. Large caps underperformed mid
and small caps this quarter. Among major EM markets, South Korea and Taiwan
outperformed, while Saudi Arabia and China underperformed.

 

Top 10 Holdings

 

 Top 10 holdings (as at 30 June 2025)  Country       % of NAV  
 1. TSMC                               Taiwan        8.7       
 1. Alibaba Group Holding              China/HK      3.0       
 1. OneSource Specialty Pharma         India         2.6       
 1. Naspers                            South Africa  2.6       
 1. Tencent Holdings                   China/HK      2.3       
 1. Samsung Electronics                South Korea   2.1       
 1. Hong Kong Exchanges & Clearing     China/HK      1.9       
 1. SK Hynix                           South Korea   1.5       
 1. CIE Fin. Richemont                 Switzerland   1.3       
 1. Vivara Participacoes SA            Brazil        1.1       
 Total                                               27.1%     

 

Key Contributors

 2Q 2025 Key Contributors    Ending Weight (%)  Total Return (%)  Contribution to Return (bps)  
 TSMC                        8.3                +12.6             +101                          
 SK Hynix Inc                1.5                +57.6             +58                           
 Naspers Limited             2.5                +7.7              +20                           
 OneSource Specialty Pharma  2.4                +16.5             +34                           
 Vivara Participacoes SA     1.1                +38.8             +35                           

 

 

Key Detractors

 2Q 2025 Key Detractors  Ending Weight (%)  Total Return (%)  Contribution to Return (bps)  
 Alibaba Group Holding   3.3                -5.1              -15                           
 Tencent Holdings        2.3                -4.7              -15                           
 Yum China Holdings      0.5                -18.7             -14                           
 E Ink Holdings Inc      0.7                -10.7             -12                           
 Kweichow Moutai Co.     0.8                -12.2             -12                           

Source: Factset. Past performance does not predict future returns. The
performance calculation is based on GBP. Currency fluctuations will also
affect the value of an investment.

 

About Ashoka WhiteOak Emerging Markets Trust plc

 

Ashoka WhiteOak Emerging Markets Trust plc (AWEMT) is a UK investment trust
seeking to achieve long-term capital appreciation primarily through investing
in a multi-cap portfolio of equities that provide exposure to global emerging
markets. Advised by Ashoka WhiteOak Capital Pte. Ltd. (Singapore), founded by
Prashant Khemka with leading Emerging Markets investment experience.  White
Oak Capital Group has delivered an exceptional track record for its other
strategies, and has £5.3 billion in assets under management or advisory4.
Analytical approach integral to disciplined research process underpinned by
proprietary frameworks OpcoFinco™ for valuation and ABLEx™ for ESG
research.  The team at WhiteOak believes that emerging markets present
potential for higher alpha. EM markets remain under-researched and
inefficient. AWEM leverages WhiteOak's investment approach to capture the
higher alpha potential in these markets.  No fixed management fee. Manager
remuneration is aligned with alpha generation and hence shareholders'
interest.  The Investment Manager is remunerated solely as a function of
outperformance over the benchmark.

 

4 Data as at 30 June 2025. AUM data refers to aggregate assets under
management or investment advisory for WhiteOak Group.

 

Further Information

 

For further information on the Company's investment strategy and portfolio
construction approach as well as details of the portfolio market cap, regional
and sector composition please refer to the latest factsheet.

 

Investment Objective

 

To achieve long-term capital appreciation, primarily investing in equity and
equity-related securities that provide exposure to global emerging markets.

 

Summary of Investment Policy

 

The Company shall invest primarily in securities admitted to trading on any
stock exchange (which may include stock exchanges in Developed Markets) that
provide exposure to companies that are domiciled in Global Emerging Markets
(EMs), or that are domiciled in Developed Markets but at the time of
investment, derive a majority of their economic value, revenues or profits
from, or whose assets or cost base are mainly located in EMs.

 

The Company's LEI is 254900Z4X5Y7NTODRI75

 

 

- Ends -

For further information:

 

Company Secretary

 AWEMT.Cosec@jtcgroup.com  Tel: +44 (0) 20 7409 0181  
                                                      

Ashoka WhiteOak Capital Pte. Ltd

 Prashant Khemka     Via Burson Buchanan  
 Fadrique Balmaseda                       
 Ben Hayward                              

 

Marex

 Mark Thompson  Tel: +44 (0) 20 7016 6711  
 Eddie Nissen   Tel: +44 (0) 20 7016 6713  
 Priyan Rayatt  Tel: +44 (0) 20 7016 6724  

 

Burson Buchanan

 Henry Harrison-Topham  Tel: +44 (0) 20 7466 5000  
 Henry Wilson           AWEM@buchanancomms.co.uk   
                                                   

 



Copyright (c) 2025 PR Newswire Association,LLC. All Rights Reserved